Retinal Vessel Diameter Changes in COVID-19 Infected Patients

Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and v...

Full description

Saved in:
Bibliographic Details
Published inOcular immunology and inflammation Vol. 29; no. 4; pp. 645 - 651
Main Authors Aşıkgarip, Nazife, Temel, Emine, Hızmalı, Lokman, Örnek, Kemal, Sezgin, Fikriye Milletli
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 19.05.2021
Subjects
coronavirus
COVID-19
optical coherence tomography
retinal vessel diameter
COVID-19
coronavirus
optical coherence tomography
retinal vessel diameter
Online AccessGet full text

Cover

Abstract Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission. Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05). Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
AbstractList : To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). : This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission. : The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls ( = .007 and = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline ( = .001, = .019, = .037, and = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all < .05). : Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19).Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission.Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05).Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19).Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission.Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05).Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission. Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05). Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
Author Örnek, Kemal
Sezgin, Fikriye Milletli
Temel, Emine
Aşıkgarip, Nazife
Hızmalı, Lokman
Author_xml – sequence: 1
  givenname: Nazife
  surname: Aşıkgarip
  fullname: Aşıkgarip, Nazife
  organization: Kırşehir Ahi Evran Training and Research Hospital
– sequence: 2
  givenname: Emine
  surname: Temel
  fullname: Temel, Emine
  email: emine912@hotmail.com
  organization: Kırşehir Ahi Evran Training and Research Hospital
– sequence: 3
  givenname: Lokman
  surname: Hızmalı
  fullname: Hızmalı, Lokman
  organization: Kırşehir Ahi Evran University School of Medicine
– sequence: 4
  givenname: Kemal
  surname: Örnek
  fullname: Örnek, Kemal
  organization: Kırşehir Ahi Evran University School of Medicine
– sequence: 5
  givenname: Fikriye Milletli
  surname: Sezgin
  fullname: Sezgin, Fikriye Milletli
  organization: Amasya University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33497297$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1rGzEQQEVIiR2nP6Flj72sM1ppVxKh0OB81BBICKmvQrs7ahV2ta4kE_Lvs8Z2Djm0p4HhvYF5p-TYDx4J-UJhTkHCOahCMMXlvIBiXMmSCcmOyJQKzvMShDwm0y2Tb6EJOY3xGQC4UvSETBjjShRKTMn3R0zOmy5bYYzYZVfO9JgwZIs_xv_GmDmfLe5Xy6ucqmzpLTYJ2-zBJIc-xTPyyZou4uf9nJFfN9dPi5_53f3tcnF5lzesqlJuSwNYyKKmRvIasIGSSWpMrRohoGrLitYghAWsyhoBKBOGWyVrigW3omUz8m13dx2GvxuMSfcuNth1xuOwibrgklYcKIUR_bpHN3WPrV4H15vwqg8vj0C5A5owxBjQviMU9DatPqTV27R6n3b0Lj54jUtjh8GnYFz3X_vHznbeDqE3L0PoWp3MazcEG4xvXNTs3yfeAA-3jrM
CitedBy_id crossref_primary_10_3389_fpubh_2023_1196202
crossref_primary_10_1016_j_pdpdt_2022_102726
crossref_primary_10_1080_17469899_2022_2021877
crossref_primary_10_1177_20503121241296701
crossref_primary_10_3390_biomedicines12071488
crossref_primary_10_1016_j_survophthal_2024_11_009
crossref_primary_10_1038_s41598_021_98873_1
crossref_primary_10_1080_09273948_2021_1933071
crossref_primary_10_17816_OV110727
crossref_primary_10_1016_j_jcvp_2024_100196
crossref_primary_10_1113_JP281888
crossref_primary_10_1016_j_mvr_2023_104588
Cites_doi 10.1007/s10384-016-0435-3
10.2214/AJR.20.22976
10.1016/j.ajo.2013.05.021
10.1038/s41577-020-0331-4
10.1111/jth.14768
10.1007/s00417-014-2715-2
10.1016/S0140-6736(20)30937-5
10.1007/s00134-020-05985-9
10.1001/jama.287.19.2528
10.2214/AJR.20.22954
10.1002/stem.2848
10.1161/STROKEAHA.110.581017
10.3233/CH-209007
10.1016/S0140-6736(20)30183-5
10.1016/j.survophthal.2008.10.003
10.1001/jamaophthalmol.2020.1291
10.1056/NEJMoa2001316
10.1159/000342158
10.1007/s00134-020-06059-6
10.1016/S0140-6736(01)06253-5
10.21037/qims-20-546
10.1001/archopht.124.1.87
10.1080/09273948.2020.1738501
10.1001/jama.287.9.1153
10.1016/j.intimp.2020.106504
10.1148/radiol.2020201237
10.1038/mt.2011.155
10.1097/IAE.0b013e3182891dda
10.1055/a-0630-1664
10.1136/bmj.38124.682523.55
ContentType Journal Article
Copyright 2020 Taylor & Francis Group, LLC 2020
Copyright_xml – notice: 2020 Taylor & Francis Group, LLC 2020
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1080/09273948.2020.1853783
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1744-5078
EndPage 651
ExternalDocumentID 33497297
10_1080_09273948_2020_1853783
1853783
Genre Research Article
Journal Article
GroupedDBID ---
00X
03L
0BK
0R~
123
29N
36B
4.4
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
NPM
7X8
TASJS
ID FETCH-LOGICAL-c366t-f5a0e282b1a84b0ec05381aab9c7706d561b077f0e65be00137a4f98b1e24f7d3
ISSN 0927-3948
1744-5078
IngestDate Mon Jul 21 10:53:30 EDT 2025
Thu Apr 03 06:59:14 EDT 2025
Tue Jul 01 00:44:03 EDT 2025
Thu Apr 24 23:13:22 EDT 2025
Wed Dec 25 09:06:20 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords COVID-19
coronavirus
optical coherence tomography
retinal vessel diameter
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-f5a0e282b1a84b0ec05381aab9c7706d561b077f0e65be00137a4f98b1e24f7d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 33497297
PQID 2481640110
PQPubID 23479
PageCount 7
ParticipantIDs crossref_primary_10_1080_09273948_2020_1853783
crossref_citationtrail_10_1080_09273948_2020_1853783
proquest_miscellaneous_2481640110
informaworld_taylorfrancis_310_1080_09273948_2020_1853783
pubmed_primary_33497297
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-05-19
PublicationDateYYYYMMDD 2021-05-19
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-19
  day: 19
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Ocular immunology and inflammation
PublicationTitleAlternate Ocul Immunol Inflamm
PublicationYear 2021
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0011
cit0033
cit0012
cit0031
cit0010
cit0030
Consigli A (cit0032) 2019; 236
cit0019
cit0018
cit0015
cit0016
cit0013
cit0014
cit0022
cit0001
cit0023
cit0020
cit0021
Casagrande M (cit0017) 2020
cit0008
cit0009
cit0006
cit0028
cit0007
cit0029
cit0004
cit0026
cit0005
cit0027
cit0002
cit0024
cit0003
cit0025
References_xml – ident: cit0011
  doi: 10.1007/s10384-016-0435-3
– ident: cit0015
  doi: 10.2214/AJR.20.22976
– ident: cit0012
  doi: 10.1016/j.ajo.2013.05.021
– ident: cit0014
  doi: 10.1038/s41577-020-0331-4
– ident: cit0022
  doi: 10.1111/jth.14768
– ident: cit0013
  doi: 10.1007/s00417-014-2715-2
– ident: cit0002
– ident: cit0023
  doi: 10.1016/S0140-6736(20)30937-5
– start-page: 1
  year: 2020
  ident: cit0017
  publication-title: Ocul Immunol Inflamm
– ident: cit0019
  doi: 10.1007/s00134-020-05985-9
– ident: cit0026
  doi: 10.1001/jama.287.19.2528
– ident: cit0006
  doi: 10.2214/AJR.20.22954
– ident: cit0021
  doi: 10.1002/stem.2848
– ident: cit0029
  doi: 10.1161/STROKEAHA.110.581017
– ident: cit0024
  doi: 10.3233/CH-209007
– ident: cit0004
  doi: 10.1016/S0140-6736(20)30183-5
– ident: cit0010
  doi: 10.1016/j.survophthal.2008.10.003
– ident: cit0016
  doi: 10.1001/jamaophthalmol.2020.1291
– ident: cit0001
  doi: 10.1056/NEJMoa2001316
– ident: cit0009
  doi: 10.1159/000342158
– ident: cit0005
  doi: 10.1007/s00134-020-06059-6
– ident: cit0028
  doi: 10.1016/S0140-6736(01)06253-5
– ident: cit0003
– ident: cit0008
  doi: 10.21037/qims-20-546
– ident: cit0030
  doi: 10.1001/archopht.124.1.87
– ident: cit0018
  doi: 10.1080/09273948.2020.1738501
– ident: cit0025
  doi: 10.1001/jama.287.9.1153
– ident: cit0031
  doi: 10.1016/j.intimp.2020.106504
– ident: cit0007
  doi: 10.1148/radiol.2020201237
– ident: cit0020
  doi: 10.1038/mt.2011.155
– ident: cit0033
  doi: 10.1097/IAE.0b013e3182891dda
– volume: 236
  start-page: 1318
  year: 2019
  ident: cit0032
  publication-title: Klin Monbl Augenheilkd
  doi: 10.1055/a-0630-1664
– ident: cit0027
  doi: 10.1136/bmj.38124.682523.55
SSID ssj0004991
Score 2.3397787
Snippet Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25...
: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). : This study included 25 patients with...
Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19).Methods: This study included 25...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 645
SubjectTerms coronavirus
COVID-19
optical coherence tomography
retinal vessel diameter
Title Retinal Vessel Diameter Changes in COVID-19 Infected Patients
URI https://www.tandfonline.com/doi/abs/10.1080/09273948.2020.1853783
https://www.ncbi.nlm.nih.gov/pubmed/33497297
https://www.proquest.com/docview/2481640110
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZbCmMvY7-XdRserI8uli1L1mOSJmSjbcZISt6EZMujpHZK677kr-_Jkh2HZbTbizECOebu85fvpLsTQt9wBio9Y9yHv4PQB5aM_UQGGXxXNMjikCekrq06O6fTBfmxjJfbtLG6uqRSx-lmb13J_3gVxsCvpkr2HzzbPhQG4B78C1fwMFwf5eNfpl4ZbHxhGoAb-pKFyW5xJQN1putodvH9xMcciMAkboC8_Gk7qd52ZenMZaOaYpFuU6Yc8FLs7NUPjkbxEZ8YDTrEq98QaV9bkt5c5i1G5rqwm__jorNtP7WTNoW8snf1msB6VWwBarbtOb0p9crWDBXOAm5ZIsRmR92Rn2VSRogPYtOSq94z5ug35B2YkQ6XUttn8g-Od0mRHIQXr7PzQhgE1cHsiTi7PbXPZ2KyOD0V8_Fy_hQdhBBMhD10MBieDCfb-llen6zYvl5T6WV6sO_7mR0Ns9Ph9u9xSq1X5i_RCxdoeAOLmlfoiS5fo2dnLpXiDWrA41nweA14PAce77L0GvB4DXi8Bjxv0WIyno-mvjtLw08jSis_j2WgIbxWWCZEBToF8k2wlIqnjAU0AxmtAsbyQNNY6brbrCQ5TxTWIclZFr1DvXJd6g_IS1lsggSmiOSEh0mSRipSgcyo0pgp2keksY5IXaN5c97JlcBNP1pnVGGMKpxR--i4nXZtO608NIF3TS-qeokrt-fRiOiBuV8bPwngU7NJJku9vrsVIUkwJUYV99F768D2daKIcAhG2cdHzD5Ez7efxSfUq27u9GfQr5X64uB3D_Nqiwg
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+Vessel+Diameter+Changes+in+COVID-19+Infected+Patients&rft.jtitle=Ocular+immunology+and+inflammation&rft.au=A%C5%9F%C4%B1kgarip%2C+Nazife&rft.au=Temel%2C+Emine&rft.au=H%C4%B1zmal%C4%B1%2C+Lokman&rft.au=%C3%96rnek%2C+Kemal&rft.date=2021-05-19&rft.issn=1744-5078&rft.eissn=1744-5078&rft.volume=29&rft.issue=4&rft.spage=645&rft_id=info:doi/10.1080%2F09273948.2020.1853783&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0927-3948&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0927-3948&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0927-3948&client=summon